Intelligent Industries of Ukraine: Major Players and Trends in the Pharmaceutical Industry
Journal: Herald of the Economic Sciences of Ukraine (Vol.39, No. 2)Publication Date: 2020-12-20
Authors : Bryukhovetskaya N. Ivanenko L.;
Page : 3-8
Keywords : intellectualized Industries; pharmaceutical industry trends; major industry players; government support instruments.;
Abstract
The results of a study of the current state and development trends of domestic enterprises-manufacturers of pharmaceutical products and drugs, the relevance of which is due to the need for scientific and methodological support of digital transformation of business models of enterprises in the real sector of the Ukrainian economy, are presented. In the context of aggravated competition, the need to create conditions for the development of the domestic pharmaceutical industry is characterized by specific innovative processes, a complex structure, a large number of high-tech jobs, high investment attractiveness, is an essential condition for improving the quality and competitiveness of pharmaceutical products in the domestic market, intellectualization of enterprises. The purpose of the article is to establish trends in the development of pharmaceutical enterprises to further determine the methods of functioning and development of intellectualized industries in Ukraine. It has been determined that during crisis periods, the dynamics of industrial production of enterprises with a high level of intellectualization is characterized by relative stability against the background of a general decline in business activity. The influence of changes in the direction of global trends in the development of the world pharmaceutical market on the domestic pharmaceutical industry has been established: a double-digit growth trend in sales of prescription drugs (double-digit growth) persists due to the implementation of the reimbursement mechanism, as well as an increase in hospital purchases. Maintaining the market growth trend and the corresponding prolongation of state programs such as “Affordable Medicines” contributes to an increase in demand in the domestic market, which can become a stimulating factor for the further development of domestic pharmaceutical manufacturers – the growth of their business, innovation and investment activity. The analysis indicates a high level of resilience of the pharmaceutical industry and the enterprises that form it to crisis influences, optimistic expectations regarding further moderate growth in the industry, potential growth in the investment attractiveness of domestic enterprises and their high adaptability to transformations of the business model towards its further digitalization and intellectualization.
Other Latest Articles
- LEGAL PROTECTION OF INVESTMENT ACTIVITIES IN UKRAINE
- QUALITY STANDARDS FOR ADMINISTRATIVE SERVICES
- THE ROLE OF LEGAL ACTS OF MANAGEMENT IN THE FIELD OF PROTECTION OF INTELLECTUAL PROPERTY RIGHTS
- NATIONAL CYBER SECURITY SYSTEM OF UKRAINE: PERSPECTIVES OF POLICY DEVELOPMENT AND CAPACITY BUILDING
- HUMAN CENTRISM IN PUBLIC MANAGEMENT: TOWARD A THEORY
Last modified: 2021-03-16 22:31:37